Mycoses — Infectology

Internal Medicine · Clinical Specialties

How it begins

Estudio exhaustivo de las infecciones fúngicas sistémicas, oportunistas y endémicas — patogénesis, biología molecular, espectro clínico, diagnóstico micológico avanzado y farmacología antifúngica de precisión.

What it covers

1. Generalities and Classification of Mycoses
2. · 1.1 Biology of the Pathogenic Fungus
3. · 1.2 Classification of Mycoses
4. · 1.3 Pathogenesis and Virulence Factors
5. Mycological Diagnosis
6. · 2.1 Microscopy and Culture
7. · 2.2 Biomarkers in Serum and Other Fluids
8. · 2.3 Molecular Diagnosis — PCR and Sequencing
9. Candidiasis
10. · 3.1 Invasive Candidiasis and Candidemia
11. · 3.2 Chronic Disseminated Candidiasis (Hepatosplenic)
12. · 3.3 Mucocutaneous Candidiasis
13. · 3.4 Antifungal Resistance in Candida — Mechanisms
14. Aspergillosis
15. · 4.1 Invasive Aspergillosis (IA)
16. · 4.2 Chronic and Non-Invasive Forms of Aspergillosis
17. Mucormycosis
18. · 5.1 Clinical Forms and Risk Factors
19. Cryptococcosis
20. · 6.1 Pathogenesis of CNS Tropism
21. · 6.2 Clinical Manifestations and Diagnosis
22. Endemic Dimorphic Mycoses
23. · 7.1 Histoplasmosis
24. · 7.2 Coccidioidomycosis
25. · 7.3 Blastomycosis
26. · 7.4 Paracoccidioidomycosis
27. · 7.5 Talaromycosis (formerly Penicilliosis)
28. Pneumocystis jirovecii — PCP pneumonia
29. · 8.1 Clinic, Diagnosis and Treatment
30. Subcutaneous Mycoses
31. · 9.1 Sporotrichosis
32. · 9.2 Chromoblastomycosis
33. · 9.3 Mycetoma
34. Superficial and Cutaneous Mycoses
35. · 10.1 Dermatophytosis (Ringworms)
36. · 10.2 Pityriasis Versicolor (Malassezia)
37. Pharmacology of Antifungals
38. · 11.1 Polyenes — Amphotericin B
39. · 11.2 Azoles — Ergosterol Biosynthesis Inhibitors
40. · 11.3 Echinocandins — β-Glucan Synthase Inhibitors
41. · 11.4 Other Antifungals and Emerging Drugs
42. Antifungal Prophylaxis in the Immunocompromized Host